Eliot Richard Forster, Ph.D.
Chairman
Protalix BioTherapeutics, Inc. (PLX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eliot Richard Forster, Ph.D.
Eliot Richard Forster, Ph.D. is recorded as Chairman at Protalix BioTherapeutics, Inc. (PLX). Protalix BioTherapeutics, Inc. reported in an 8-K filed September 12, 2023 that Eliot Richard Forster, Ph.D. was appointed Chairman of the Company's Board of Directors, effective September 14, 2023.
“On September 12, 2023, Protalix BioTherapeutics, Inc. (the "Company") announced the appointment by its Board of Directors of Eliot Richard Forster, Ph.D. as Chairman of the Company's Board of Directors effective as of September 14, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-09-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Protalix BioTherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Dror Bashan CEO, Board Member
- Eliot Richard Forster Chairman
- Gilad Mamlok CFO
- Aharon Schwartz Board Member
- Amos Bar Shalev Board Member
- Christian Elze Board Member
- Gwen A. Melincoff Board Member
- Pol F. Boudes Board Member
- Shmuel Ben Zvi, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.